Skip to main content

Selentus Science Limited

The startup develops a medical device that utilizes a novel hemostatic technology to control bleeding during surgical procedures without relying on blood-derived materials. This approach reduces the risk of contamination and minimizes postoperative hemorrhage, offering a safer alternative to traditional blood products.

Traction 2/10
Nottingham, United Kingdom · HQ
Founded 20165100+ followers
  • Biotechnology
  • Healthcare Technology
  • Medical Devices
Updated 6 months ago

Funding

Raised to date

$770KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

Paul Hayes

Surgeon, Innovator and Founder

Product

Features

  • The startup develops a medical device that utilizes a novel hemostatic technology to control bleeding during surgical procedures without relying on blood-derived materials. This approach reduces the risk of contamination and minimizes postoperative hemorrhage, offering a safer alternative to traditional blood products.
This profile is AI-generated and may contain inaccuracies.